Illumina | ILMN - Nettoeinkommen

Aktienkurs
125.57
Täglich Wechseln
5.20 4.32%
Monatlich
1.87%
Jährlich
64.12%
Q2 Prognose
125.14




Nettoeinkommen Veränderung Datum
Agilent USD 305M 129M 2025-12
Bio Techne USD 38.01M 176K 2025-12
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Boston Scientific USD 1.34B 669M 2026-03
Bruker USD 26M 88.4M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Danaher USD 1.03B 168M 2026-03
Dentsply International USD -146M 281M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Illumina USD 334M 184M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 251M 6M 2026-03
Quidel USD -733M 477.6M 2025-09
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Waters USD 225.21M 76.29M 2025-12